On the other hand, in gastric tumors with patchy HER2 membrane localization, the pharmacological depletion of caveolin 1 successfully forces HER2 to the cell surface for improved trastuzumab and pertuzumab efficacy [33,34]. This evidence concerns the gene ERBB2 and gastric neoplasm.